Loading clinical trials...
Loading clinical trials...
This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
New York State Psychiatric Institute
Collaborators
NCT07124780 · Obsessive-Compulsive Disorder (OCD)
NCT05623306 · Obsessive-Compulsive Disorder
NCT06647589 · Obsessive-Compulsive Disorder (OCD)
NCT06585618 · Dystonia, Epilepsy in Children, and more
NCT06804525 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more
New York State Psychiatric Insitute
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions